Have a personal or library account? Click to login

Olfactory functions in Behçet’s disease: A review

Open Access
|Nov 2018

References

  1. 1. Alnaimat FA. Behcet Disease [Internet]. Medscape [update Dec 27, 2007]. Available from: http://emedicine.medscape.com/article/329099-overview#showall. Accessed February 17, 2017.
  2. 2. Alpsoy E. Behçet’s disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43(6):620-32. DOI: 10.1111/1346-8138. Epub 2016 Apr 14.2707594210.1111/1346-8138.Epub2016Apr14
  3. 3. Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, et al. Familial aggregation in Behçet’s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999;135(1):89-93.10.1016/S0022-3476(99)70333-1
  4. 4. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009; 61(10):1287-96. DOI: 10.1002/art.24642.10.1002/art.24642
  5. 5. Veyseller B, Dogan R, Ozücer B, Aksoy F, Meric A, Su O, et al. Olfactory function and nasal manifestations of Behçet’s disease. Auris Nasus Larynx. 2014;41(2):185-9. DOI: 10.1016/j.anl.2013.07.014. Epub 2013 Oct 30.2418339710.1016/j.anl.2013.07.014.Epub2013Oct30
  6. 6. Ozbay I, Kucur C, Temizturk F, Ozkan Y, Kahraman C, Oghan F. Assessment of nasal mucociliary activity in patients with Behçet’s disease. J Laryngol Otol. 2016;130(4):348-51. DOI: 10.1017/S0022215116000207. Epub 2016 Feb 4.10.1017/S0022215116000207.Epub2016Feb4
  7. 7. Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel. Clin Rheumatol. 2007;26(4):555-60. Epub 2006 Aug 1.10.1007/s10067-006-0349-4
  8. 8. Sakane T, Suzuki N, Takeno M. Innate and acquired immunity in Behçet’s disease. 8th International Congress on Behçet’s Disease. Reggio Emilia, Italy, 7-9 October 1998. Program and Abstracts: 56.
  9. 9. Emmi L, Brugnolo F, Salvati G, Marchione T. Immunopathological aspects of Behçet’s disease. Clin Exp Rheumatol. 1995;13(6):687-91.8835239
  10. 10. Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T, et al. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet’s disease. J Rheumatol. 2000;27(3):708-13.
  11. 11. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet’s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999;42(9):1967-74.10.1002/1529-0131(199909)42:9<;1967::AID-ANR24>3.0.CO;2-Z
  12. 12. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M. Increased frequencies of interleukin-2-and interferon-gamma-producing T cells in patients with active Behçet’s disease. Invest Ophthalmol Vis Sci. 1998;39(6):996-1004.
  13. 13. Hamzaoui K, Berraies A, Kaabachi W, Ammar J, Hamzaoui A. Pulmonary manifestations in Behcet disease: impaired natural killer cells activity. Multidiscip Respir Med.2013;8(1):29. DOI: 10.1186/2049-6958-8-29.10.1186/2049-6958-8-29
  14. 14. Dhong HJ, Kim HY, Ha BS. Histologic changes to olfactory epithelium in hypothyroid rats. Otolaryngol Head Neck Surg. 2003;129(1):24–32.10.1016/S0194-5998(03)00530-8
  15. 15. Akyol L, Günbey E, Karlı R, Önem S, Özgen M, Sayarlıoğlu M. Evaluation of olfactory function in Behçet’s disease. Eur J Rheumatol. 2016;3(4):153-6. DOI: 10.5152/eurjrheum.2016.017. Epub 2016 Dec 1.10.5152/eurjrheum.2016.017.Epub2016Dec1
  16. 16. Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope. 2000;110(7):1071–7.10.1097/00005537-200007000-00001
  17. 17. Callahan CD, Hinkebein JH. Assessment of anosmia after traumatic brain injury: performance characteristics of the University of Pennsylvania Smell Identification Test. J Head Trauma Rehabil. 2002;17(3):251–6.10.1097/00001199-200206000-00006
  18. 18. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord. 2003;18(4):364–72.1267194110.1002/mds.10379
  19. 19. Klimek L, Moll B, Amedee RG, Mann WJ. Olfactory function after microscopic endonasal surgery in patients with nasal polyps. Am J Rhinol. 1997;11(4):251-5.10.2500/105065897781446621
  20. 20. Landis BN, Scheibe M, Weber C, Berger R, Bramerson A, Bende M, et al. Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol. 2010;257(8):1303-8. DOI: 10.1007/s00415-010-5513-8. Epub 2010 Mar 11.10.1007/s00415-010-5513-8
  21. 21. Mattes RD. Physiologic responses to sensory stimulation by food: nutritional implications. J Am Diet Assoc. 1997;97(4):406-13.10.1016/S0002-8223(97)00101-6
  22. 22. Samuels MH. Psychiatric and cognitive manifestations of hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):377-83. DOI: 10.1097/MED.0000000000000089.10.1097/.0000000000000089
  23. 23. Ortega-Hernandez OD, Kivity S, Shoenfeld Y. Olfaction, psychiatric disorders and autoimmunity: is there a common genetic association? Autoimmunity. 2009;42(1):80-8. DOI: 10.1080/08916930802366140.10.1080/0891693080236614019127459
  24. 24. Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, Paran D, Katz BS, Kivity S, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 2009;60(5):1484-7. DOI: 10.1002/art.24491.10.1002/art.2449119404932
  25. 25. O’Devaney K, Ferlito A, Devaney SL, Huner BC, Rinaldo A. Wegener’s granulomatosis of the head and neck. Ann Otol Rhinol Laryngol. 1996;107:439-45. DOI: 10.1177/000348949810700515.10.1177/0003489498107005159596226
  26. 26. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrouse B, Casassus P. Churg–Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78(1):26-37.10.1097/00005792-199901000-000039990352
  27. 27. Robson AK, Burge SM, Millard PR. Nasal mucosal involvement in lupus erythematosus. Clin Otolaryngol Allied Sci. 1992;17(4):341-3.10.1111/j.1365-2273.1992.tb01009.x1526055
  28. 28. Rasmussen N, Brofeldt S, Manthorpe R. Smell and nasal findings in patients with primary Sjögren’s syndrome. Scand J Rheumatol Suppl. 1986;61:142-5.
  29. 29. Weisman RA, Calcaterra TC. Head and neck manifestations of scleroderma. Ann Otol Rhinol Laryngol. 1978;87(3 Pt 1):332-9.10.1177/000348947808700307655570
  30. 30. Rampelberg O, Gerard JM, Namias B, Gerard M. ENT manifestations of relapsing polychondritis. Acta Otorhinolaryngol Belg. 1997;51(2):73-7.
  31. 31. Peno IC, De las Heras Revilla V, Carbonell BP, Di Capua Sacoto D, Ferrer ME, Garcia-Cobos R, et al. Neurobehçet disease: clinical and demographic characteristics. Eur J Neurol. 2012;19(9):1224-7. DOI: 10.1111/j.1468-1331.2012.03706.x. Epub 2012 Apr 2.10.1111/j.1468-1331.2012.03706.x.Epub2012Apr2
  32. 32. Serdaroglu P. Behcet’s disease and the nervous system. J Neurol. 1998;245(4):197-205.10.1007/s0041500502059591220
  33. 33. Oktem-Tanör O, Baykan-Kurt B, Gürvit IH, Akman-Demir G, Serdaroğlu P. Neuropsychological follow-up of 12 patients with neuro-Behçet disease. J Neurol. 1999;246(2):113-9.10.1007/s00415005031710195406
  34. 34. Siva A, Altintas A, Saip S. Behcet’s syndrome and the nervous system. Curr Opin Neurol. 2004;17(3):347-57.1516707110.1097/00019052-200406000-0001715167071
  35. 35. Okuyucu EE, Balci DD, Balci A, Duman T, Akcin E. Neurologic soft signs in Behcet disease. Neurologist. 2010;16(6):371-4. DOI: 10.1097/NRL.0b013e3181cf86c3.10.1097/NRL.0b013e3181cf86c321150386
  36. 36. Morales-Angulo C, Vergara Pastrana S, Obeso-Agüera S, Acle L, Gonzalez-Gay MA. Otorhinolaryngological manifestations in patients with Behçet disease. Acta Otorrinolaringol Esp. 2014;65(1):15-21. DOI: 10.1016/j.otorri.2013.06.007. Epub 2013 Oct 2.10.1016/j.otorri.2013.06.007.Epub2013Oct2
  37. 37. Shahram F, Zarandy MM, Ibrahim A, Ziaie N, Saidi M, Nabaei B, et al. Nasal mucosal involvement in Behcet disease: a study of its incidence and characteristics in 400 patients. Ear Nose Throat J. 2010;89(1):30-3.10.1177/014556131008900109
  38. 38. Morales-Angulo C, García-Zornoza R, Obeso-Agüera S, Calvo-Alén J, González-Gay MA. Ear, nose and throat manifestations of Wegener’s granulomatosis (granulomatosis with polyangiitis). Acta Otorrinolaringol Esp.2012;63(3):206-11. DOI: 10.1016/j.otorri.2011.12.002. Epub 2012 Mar 20.10.1016/j.otorri.2011.12.002.Epub201220
  39. 39. Meric A, Dogan R, Su O, Eren SB, Tugrul S, Ozturan O. Correlation of Otorhinolaryngologic Symptoms with Physical Findings in Behçet’s Disease. B-ENT. 2015;11(1):31-7.
  40. 40. Rashid RM, Miller A, Scianna JM, Stankiewicz JA. Chronic rhinosinusitis and psoriasis: do mutually exclusive systemic Th1 and Th2 disease patterns exist? Acta Otolaryngol. 2007;127(7):780-3.10.1080/0001648060100205417573576
  41. 41. Verim A, Cebeci F, Baser E, Calim ÖF, Kadioğlu D, Kocagöz GD. Prevalence of chronic rhinosinusitis in the setting of Behçet disease. J Craniofac Surg. 2015;26(1):186-90. DOI: 10.1097/SCS.0000000000001202.10.1097/SCS.000000000000120225469896
  42. 42. Direskeneli H. Autoimmunity vs autoinflammation in Behcet’s disease: do we oversimplify a complex disorder? Rheumatology. 2006;45(12):1461-5. Epub 2006 Sep 23.10.1093/rheumatology/kel32916998234
  43. 43. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003;4(7):441-7.10.2165/00128071-200304070-0000112814334
  44. 44. Kennedy JL, Borish L. Chronic sinusitis pathophysiology: The role of allergy. Am J Rhinol Allergy. 2013;27(5):367-71. DOI: 10.2500/ajra.2013.27.3906.10.2500/ajra.2013.27.3906378138923601202
DOI: https://doi.org/10.2478/rjr-2018-0023 | Journal eISSN: 2393-3356 | Journal ISSN: 2069-6523
Language: English
Page range: 213 - 217
Submitted on: Jul 3, 2018
Accepted on: Aug 3, 2018
Published on: Nov 2, 2018
Published by: Romanian Rhinologic Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Nuray Bayar Muluk, published by Romanian Rhinologic Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.